latest news releases from the newsroom
Skanska Signs Agreement on Sale of Skanska Services
STOCKHOLM, Sweden, Oct. 1, 2004 (PRIMEZONE) -- Skanska and 3i, an international private equity company, have signed a binding agreement covering the sale of Skanska Services. The sale is conditional upon approval by the European Commission.
Metro Launches New Edition in Holland
BERTRANGE, Luxembourg, Oct. 1, 2004 (PRIMEZONE) -- Metro International S.A. ("Metro"), the international newspaper group, today announced that Metro Holland will launch a new edition in Rotterdam on Monday 4 October. 120,000 copies of the new edition will be distributed six days a week in the second largest city in Holland, including the 70,000 national edition copies that are currently distributed in Rotterdam and will now be converted into the local format featuring both national and local news, as well as a localized front cover.
Maxim Pharmaceuticals Presents Preclinical Results of Novel Cancer Compound Discovered by Its Research Team at The AACR-EORTC
STOCKHOLM, Sweden and SAN DIEGO, Oct. 1, 2004 (PRIMEZONE) -- Maxim Pharmaceuticals (Nasdaq:MAXM) (SSE:MAXM) reported earlier this week at the AACR-EORTC-NCI International Conference "Molecular Targets and Cancer Therapeutics" in Geneva, Switzerland, that MX2167, a novel anticancer agent discovered by its research team and under development, targets the transferrin receptor leading to a previously unknown rapid induction of apoptosis (programmed cell death) in preclinical tumor models. The transferrin receptor is located on the surface of cells and is overexpressed in several types of cancer. Although it is a known and validated oncology target, this is the first evidence describing its role as a rapid inducer of apoptosis when targeted with MX2167. "These preclinical results demonstrate the potential for MX2167 as an anticancer agent with a molecular mechanism unique from currently available cancer drugs. This pioneering work by Maxim scientists may also have important implications for developing a new class of anticancer drugs that specifically target the transferrin receptor," stated Larry Stambaugh, President and CEO of Maxim Pharmaceuticals.
Liquid Acoustics Ships Speakers to South Korean Buyers
BUENA PARK, Calif., Sept. 30, 2004 (PRIMEZONE) -- Liquid Acoustics (www.liquidacoustics.com) announced today that they have signed a distribution agreement to sell their speaker products to South Koreans. We are very pleased to have Campia Trading as our partners in South Korea, said a company spokesperson. This is a perfect example of a United States-made speaker product having foreign appeal, both from the financial and performance end, says the company.
General Environmental Management, Inc.
General Environmental Management, Inc. (GEM) Announces John A. Brunkow to Head Software Effort and Application Software Name Change to GEMWARE
POMONA, Calif., Sept. 30, 2004 (PRIMEZONE) -- General Environmental Management, Inc. (GEM) (www.go-gem.com), a leading environmental and remediation company, announced today that it has consolidated the roles of CEO and Chairman of the Board with the current CEO Tim Koziol. The combining of the positions is intended to create a unilateral voice to shareholders and key clients, and more importantly to allocate more time for the company's current Chairman John A. Brunkow, a founding shareholder and IBM veteran, to provide specific guidance on the continued development and growth of the company's application software.
More Utilities Automate Customer Communications, Says New Chartwell Report
ATLANTA, Sept. 30, 2004 (PRIMEZONE) -- While more than 70% of utilities use outbound calling as a way to proactively communicate with customers, a growing number are turning to automated applications to conduct outbound communications, according to Chartwell's latest report, Automated Outbound Communications: Notification, Courtesy Calls and Other Proactive Measures.